Clinical Trial Update: The Immunogenicity of Simultaneous Administration of Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Vaccine [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated the immunogenicity of administering the quadrivalent influenza vaccine simultaneously with the 23-valent pneumococcal vaccine…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Pneumonia

Drugs mentioned

• Pneumococcal polysaccharide vaccine (23-valent) (pneumococcal polysaccharide vaccine (23-valent))
• Quadrivalent influenza vaccine (influenza vaccine, quadrivalent)

Snippet

Sponsor: Kameda Medical Center | Conditions: Pneumococcal Pneumonia, Influenza | Phase 4 | Status: COMPLETED | Results posted: 2019-01-31